Financials Diaceutics PLC

Equities

DXRX

GB00BJQTGV64

Business Support Services

Market Closed - London S.E. 11:35:11 2024-06-05 am EDT 5-day change 1st Jan Change
132 GBX -0.38% Intraday chart for Diaceutics PLC -0.75% +51.72%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Capitalization 1 70.97 112.2 85.75 63.68 111.4 111.4 -
Enterprise Value (EV) 1 59.25 87.1 66.08 43.84 73.32 97.71 96.25
P/E ratio 165 x 393 x - 89.9 x -42 x -64.1 x 95.7 x
Yield - - - - - - -
Capitalization / Revenue 5.3 x 8.84 x 6.15 x 3.26 x 3.09 x 3.77 x 2.96 x
EV / Revenue 4.42 x 6.86 x 4.74 x 2.25 x 3.09 x 3.31 x 2.56 x
EV / EBITDA 24.7 x 162 x 28.1 x 12.2 x 31.1 x 35 x 14.1 x
EV / FCF - - -13.1 x 194 x -24.3 x -28.1 x 69.8 x
FCF Yield - - -7.61% 0.52% -4.11% -3.56% 1.43%
Price to Book - - - 1.53 x 2.71 x 2.91 x 2.76 x
Nbr of stocks (in thousands) 69,583 84,069 84,069 84,339 84,427 84,427 -
Reference price 2 1.020 1.335 1.020 0.7550 1.325 1.325 1.325
Announcement Date 3/16/20 3/15/21 3/22/22 4/17/23 5/21/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net sales 1 13.4 12.7 13.94 19.5 23.7 29.54 37.6
EBITDA 1 2.4 0.539 2.349 3.583 2.357 2.79 6.816
EBIT 1 0.7404 -0.658 0.55 0.574 -3.018 -2.493 1.335
Operating Margin 5.53% -5.18% 3.94% 2.94% -12.73% -8.44% 3.55%
Earnings before Tax (EBT) 1 0.4973 -0.682 - 0.564 -2.438 -2.271 1.358
Net income 1 0.3979 0.263 0.561 0.724 -1.746 -2.215 0.692
Net margin 2.97% 2.07% 4.02% 3.71% -7.37% -7.5% 1.84%
EPS 2 0.006200 0.003400 - 0.008400 -0.0207 -0.0207 0.0138
Free Cash Flow 1 - - -5.031 0.226 -3.92 -3.475 1.379
FCF margin - - -36.08% 1.16% -16.45% -11.76% 3.67%
FCF Conversion (EBITDA) - - - 6.31% - - 20.23%
FCF Conversion (Net income) - - - 31.22% - - 199.29%
Dividend per Share 2 - - - - - - -
Announcement Date 3/16/20 3/15/21 3/22/22 4/17/23 5/21/24 - -
1GBP in Million2GBP
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 S1 2022 S1 2022 S2 2023 S1 2023 S2 2024 S1 2024 S2
Net sales 1 - - 11.98 9.924 13.78 11.9 17.5
EBITDA 1 - - 3.31 -0.232 2.589 0.1 2.7
EBIT 1 - - 1.637 -2.166 -0.852 -2.5 0.2
Operating Margin - - 13.67% -21.83% -6.19% -21.01% 1.14%
Earnings before Tax (EBT) 1 - - 1.695 -1.955 -0.483 -2.4 0.2
Net income 1 -0.335 -0.767 1.491 -1.485 -0.261 -2.2 0.4
Net margin - - 12.45% -14.96% -1.89% -18.49% 2.29%
EPS 2 -0.004000 -0.009100 0.0173 -0.0176 -0.003100 -0.0257 0.005100
Dividend per Share - - - - - - -
Announcement Date 9/14/21 9/27/22 4/17/23 9/26/23 5/21/24 - -
1GBP in Million2GBP
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025
Net Debt 1 - - - - - - -
Net Cash position 1 11.7 25.1 19.7 19.8 16 13.7 15.2
Leverage (Debt/EBITDA) - - - - - - -
Free Cash Flow 1 - - -5.03 0.23 -3.92 -3.47 1.38
ROE (net income / shareholders' equity) - - - - - - -
ROA (Net income/ Total Assets) - - - - - - -
Assets 1 - - - - - - -
Book Value Per Share 2 - - - 0.4900 0.4900 0.4600 0.4800
Cash Flow per Share - - - - - - -
Capex 1 2.93 6.29 5.6 4.87 6.1 5.57 5.57
Capex / Sales 21.84% 49.57% 40.17% 24.97% 25.6% 18.85% 14.81%
Announcement Date 3/16/20 3/15/21 3/22/22 4/17/23 5/21/24 - -
1GBP in Million2GBP
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
1.32 GBP
Average target price
1.718 GBP
Spread / Average Target
+30.15%
Consensus
  1. Stock Market
  2. Equities
  3. DXRX Stock
  4. Financials Diaceutics PLC